Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Dubr | Mouse | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of DUBR mRNA | CTD | PMID:29581250 | Dubr | Mouse | acrylamide | decreases expression | ISO | DUBR (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of DUBR mRNA | CTD | PMID:32763439 | Dubr | Mouse | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DUBR mRNA | CTD | PMID:27858113 | Dubr | Mouse | benzo[a]pyrene | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of DUBR mRNA | CTD | PMID:32234424 | Dubr | Mouse | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DUBR mRNA | CTD | PMID:27858113 | Dubr | Mouse | beta-lapachone | decreases expression | ISO | DUBR (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of DUBR mRNA | CTD | PMID:38218311 | Dubr | Mouse | bisphenol A | decreases methylation | ISO | DUBR (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of DUBR gene | CTD | PMID:31601247 | Dubr | Mouse | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of DUBR mRNA | CTD | PMID:38685157 | Dubr | Mouse | chrysene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DUBR mRNA | CTD | PMID:27858113 | Dubr | Mouse | cisplatin | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | Cisplatin results in increased expression of DUBR mRNA | CTD | PMID:27392435 | Dubr | Mouse | cisplatin | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of DUBR mRNA | CTD | PMID:27392435 | Dubr | Mouse | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of DUBR mRNA | CTD | PMID:29279043 | Dubr | Mouse | dorsomorphin | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Dubr | Mouse | doxorubicin | decreases expression | ISO | DUBR (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of DUBR mRNA | CTD | PMID:29803840 | Dubr | Mouse | mercury dibromide | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of DUBR mRNA | CTD | PMID:26272509 | Dubr | Mouse | mercury dibromide | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUBR mRNA | CTD | PMID:27188386 | Dubr | Mouse | methotrexate | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | Methotrexate results in increased expression of DUBR mRNA | CTD | PMID:24449571 | Dubr | Mouse | methylmercury chloride | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of DUBR mRNA | CTD | PMID:26272509 | Dubr | Mouse | methylmercury chloride | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUBR mRNA | CTD | PMID:27188386 | Dubr | Mouse | perfluorohexanesulfonic acid | increases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in increased expression of DUBR mRNA | CTD | PMID:37995155 | Dubr | Mouse | phenylmercury acetate | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of DUBR mRNA | CTD | PMID:26272509 | Dubr | Mouse | phenylmercury acetate | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUBR mRNA | CTD | PMID:27188386 | Dubr | Mouse | SB 431542 | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Dubr | Mouse | sodium arsenite | decreases expression | ISO | DUBR (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of DUBR mRNA | CTD | PMID:38568856 | Dubr | Mouse | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of DUBR mRNA | CTD | PMID:30529165 | Dubr | Mouse | tetraphene | decreases expression | EXP | | 6480464 | benz(a)anthracene results in decreased expression of DUBR mRNA | CTD | PMID:26377693 | Dubr | Mouse | tetraphene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DUBR mRNA | CTD | PMID:27858113 | Dubr | Mouse | thimerosal | decreases expression | ISO | DUBR (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of DUBR mRNA | CTD | PMID:27188386 | Dubr | Mouse | trichostatin A | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | trichostatin A results in increased expression of DUBR mRNA | CTD | PMID:27188386 | Dubr | Mouse | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of DUBR mRNA | CTD | PMID:33045310 | Dubr | Mouse | valproic acid | affects expression | ISO | DUBR (Homo sapiens) | 6480464 | Valproic Acid affects the expression of DUBR mRNA | CTD | PMID:25979313 | Dubr | Mouse | valproic acid | multiple interactions | ISO | DUBR (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUBR mRNA | CTD | PMID:27188386 | Dubr | Mouse | valproic acid | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of DUBR mRNA | CTD | PMID:24935251 more ... | Dubr | Mouse | vorinostat | increases expression | ISO | DUBR (Homo sapiens) | 6480464 | vorinostat results in increased expression of DUBR mRNA | CTD | PMID:27188386 | |